263 related articles for article (PubMed ID: 17886246)
1. 20-(S)-camptothecin analogues as DNA topoisomerase I inhibitors: a QSAR study.
Hansch C; Verma RP
ChemMedChem; 2007 Dec; 2(12):1807-13. PubMed ID: 17886246
[TBL] [Abstract][Full Text] [Related]
2. Understanding topoisomerase I and II in terms of QSAR.
Verma RP
Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
[TBL] [Abstract][Full Text] [Related]
3. Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues.
Lavergne O; Lesueur-Ginot L; Pla Rodas F; Kasprzyk PG; Pommier J; Demarquay D; Prévost G; Ulibarri G; Rolland A; Schiano-Liberatore AM; Harnett J; Pons D; Camara J; Bigg DC
J Med Chem; 1998 Dec; 41(27):5410-9. PubMed ID: 9876111
[TBL] [Abstract][Full Text] [Related]
4. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: a QSAR study.
Hansch C; Verma RP
Mol Pharm; 2009; 6(3):849-60. PubMed ID: 19334723
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
[TBL] [Abstract][Full Text] [Related]
6. Novel camptothecin derivatives as topoisomerase I inhibitors.
Basili S; Moro S
Expert Opin Ther Pat; 2009 May; 19(5):555-74. PubMed ID: 19441934
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, topoisomerase I inhibitory activity and in vitro cytotoxicity of camptothecin derivatives bearing five-membered heterocycle containing 10-substituents.
Zhao R; Guan LL; Oreski B; Lown JW
Anticancer Drug Des; 1998 Mar; 13(2):145-57. PubMed ID: 9524556
[TBL] [Abstract][Full Text] [Related]
8. Understanding human rhinovirus infections in terms of QSAR.
Verma RP; Hansch C
Virology; 2007 Mar; 359(1):152-61. PubMed ID: 17045322
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.
Fox BM; Xiao X; Antony S; Kohlhagen G; Pommier Y; Staker BL; Stewart L; Cushman M
J Med Chem; 2003 Jul; 46(15):3275-82. PubMed ID: 12852757
[TBL] [Abstract][Full Text] [Related]
10. Taxane analogues against breast cancer: a quantitative structure-activity relationship study.
Verma RP; Hansch C
ChemMedChem; 2008 Apr; 3(4):642-52. PubMed ID: 18196507
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
[TBL] [Abstract][Full Text] [Related]
12. Camptothecin conjugated with DNA minor-groove binder netropsin: enhanced lactone stability, inhibition of human DNA topoisomerase I and antiproliferative activity.
Sukhanova A; Grokhovsky S; Zhuze A; Devy J; Pluot M; Oleinikov V; Nabiev I
Anticancer Res; 2003; 23(3B):2609-15. PubMed ID: 12894548
[TBL] [Abstract][Full Text] [Related]
13. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A
Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837
[TBL] [Abstract][Full Text] [Related]
14. Total and semisynthesis and in vitro studies of both enantiomers of 20-fluorocamptothecin.
Tangirala RS; Dixon R; Yang D; Ambrus A; Antony S; Agama K; Pommier Y; Curran DP
Bioorg Med Chem Lett; 2005 Nov; 15(21):4736-40. PubMed ID: 16140529
[TBL] [Abstract][Full Text] [Related]
15. QSAR modeling of taxane analogues against colon cancer.
Verma RP; Hansch C
Eur J Med Chem; 2010 Apr; 45(4):1470-7. PubMed ID: 20116905
[TBL] [Abstract][Full Text] [Related]
16. Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.
Manikumar G; Wadkins RM; Bearss D; Von Hoff DD; Wani MC; Wall ME
Bioorg Med Chem Lett; 2004 Nov; 14(21):5377-81. PubMed ID: 15454230
[TBL] [Abstract][Full Text] [Related]
17. Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin.
Lackey K; Sternbach DD; Croom DK; Emerson DL; Evans MG; Leitner PL; Luzzio MJ; McIntyre G; Vuong A; Yates J; Besterman JM
J Med Chem; 1996 Feb; 39(3):713-9. PubMed ID: 8576914
[TBL] [Abstract][Full Text] [Related]
18. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
Holden JA; Wall ME; Wani MC; Manikumar G
Arch Biochem Biophys; 1999 Oct; 370(1):66-76. PubMed ID: 10496978
[TBL] [Abstract][Full Text] [Related]
19. Camptothecin: current perspectives.
Thomas CJ; Rahier NJ; Hecht SM
Bioorg Med Chem; 2004 Apr; 12(7):1585-604. PubMed ID: 15028252
[TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR study on heterocyclic topoisomerase II inhibitors using CoMSIA.
Tekiner-Gulbas B; Temiz-Arpaci O; Yildiz I; Aki-Sener E; Yalcin I
SAR QSAR Environ Res; 2006 Apr; 17(2):121-32. PubMed ID: 16644553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
